Chemistry and pharmacology of fluorinated drugs approved by the FDA (2016–2022)

G Shabir, A Saeed, W Zahid, F Naseer, Z Riaz… - Pharmaceuticals, 2023 - mdpi.com
Fluorine is characterized by high electronegativity and small atomic size, which provide this
molecule with the unique property of augmenting the potency, selectivity, metabolic stability …

PET imaging in prostate cancer: focus on prostate-specific membrane antigen

RC Mease, CA Foss, MG Pomper - Current topics in medicinal …, 2013 - ingentaconnect.com
Prostate cancer (PCa) is the second leading cause of cancer-related death in American
men. Positron emission tomography/computed tomography (PET/CT) with emerging …

Clinical PET imaging in prostate cancer

KL Wallitt, SR Khan, S Dubash, HH Tam, S Khan… - Radiographics, 2017 - pubs.rsna.org
Prostate cancer is the second most common cancer in men worldwide, with a wide spectrum
of biologic behavior ranging from indolent low-risk disease to highly aggressive castration …

[HTML][HTML] Imaging of T-cells and their responses during anti-cancer immunotherapy

M Krekorian, GO Fruhwirth, M Srinivas, CG Figdor… - Theranostics, 2019 - ncbi.nlm.nih.gov
Imaging of T-cells and their responses during anti-cancer immunotherapy - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

N Pandit-Taskar, JA O'Donoghue, V Beylergil… - European journal of …, 2014 - Springer
Purpose Given the bone tropism of prostate cancer, conventional imaging modalities poorly
identify or quantify metastatic disease. 89 Zr-huJ591 positron emission tomography (PET) …

Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease

DM Schuster, C Nanni, S Fanti, S Oka… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid (18F-FACBC) is a synthetic amino
acid analog PET radiotracer undergoing clinical trials for the evaluation of prostate and other …

18F-fluciclovine PET/CT for the detection of prostate cancer relapse: a comparison to 11C-choline PET/CT

C Nanni, R Schiavina, E Brunocilla… - Clinical nuclear …, 2015 - journals.lww.com
Purpose In recent years, a new PET compound (anti-3-18 F-FACBC or 18 F-fluciclovine)
was tested for the detection of prostate cancer relapse. Despite very promising results, only …

Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In–Capromab Pendetide SPECT/CT

DM Schuster, B Savir-Baruch, PT Nieh, VA Master… - Radiology, 2011 - pubs.rsna.org
Purpose To compare the diagnostic performance of the synthetic amino acid analog
radiotracer anti-1-amino-3-fluorine 18-fluorocyclobutane-1-carboxylic acid (anti-3-18F …

Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results

C Nanni, R Schiavina, S Boschi, V Ambrosini… - European journal of …, 2013 - Springer
Purpose We assessed the rate of detection rate of recurrent prostate cancer by PET/CT
using anti-3-18 F-FACBC, a new synthetic amino acid, in comparison to that using 11 C …

18F-ML-10, a PET tracer for apoptosis: first human study

J Höglund, A Shirvan, G Antoni… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Clinical PET of apoptosis may have substantial value in advancing patient care. We report
here the first-in-humans study with 18F-labeled 2-(5-fluoropentyl)-2-methyl malonic acid …